The review authors sought to elucidate the neurological harms of methamphetamine, which are well-documented but poorly understood.
This prospective cohort study assessed whether PD-related brain metabolic patterns may be used as biomarkers in isolated REM sleep behavior disorder.
Studies have identified that patients who engage in exercise had improved symptoms of the disease in addition to higher quality of life, improved balance and mobility, fewer depressive symptoms, and improved thinking skills.
The study researchers reported on a self-assembled hydrogel to deliver the drug 4-dihydroxyphenylalanine (L-DOPA) for Parkinson disease.
Because sargramostim therapeutic use has been offset by dose-dependent adverse events, the researchers performed a reduced drug dose regimen to evaluate safety and to discover novel disease-linked biomarkers during sargramostim treatments for 1 year.
The researchers’ goal studied whether exposure to particulate matters, nitrogen dioxide, ozone, sulfur dioxide, or carbon monoxide raises the risk of Parkinson disease.
The system works with Medtronic’s Percept™ PC Neurostimulator.
For patients with Parkinson disease, deep brain stimulation of the subthalamic nucleus is effective beyond 15 years after implantation.
To better understand the relationship between peripheral blood monocyte activation and PD, investigators recruited a population of patients with untreated early PD.
The unprecedented numbers of patients on mechanical ventilation underscore the severity of the coronavirus on public health. Elderly patients, especially those with Parkinson disease, often bear the brunt of the pandemic due to pre-existing pulmonary disease and/or anatomical disposition.